RELEVANT REFERENCES:

PRESENTATION:

Transcriptional Dysregulation of Sirtuin 1 is Relevant to Diabetes and Global Chronic Disease

Global Experts Meeting On Diabetes, Hypertension & Metabolic Syndrome, July 30-31, 2018 , MELBOURNE, AUSTRAILA

1. Advances in Biomarkers and Insulin Therapy with Relevance to Reversal of Diabetes. Journal of Studies on Diabetes 2018; 1(1): 9-14.

2. Evaluation of diagnostic tests in human health and disease. J Clin Path Lab Med. 2018;2(1):13-15.

3. Insulin Therapy Inactivation is connected to NAFLD and Diabetes Severity Index. J Diab Clin Stud. 2017; 1: 001-003.

4. Sirtuin 1, a Diagnostic Protein Marker and its Relevance to Chronic Disease and Therapeutic Drug Interventions”. EC Pharmacology and Toxicology 6.4 (2018): 209-215.

5. The Future of Biomarkers Tests and Genomic Medicine in Global Organ Disease. Arch Infect Dis Ther. 2017; 1(1): 1-6.

6. The Limitations of Food Intake and Biomarkers in the Prevention of Chronic Diseases. Nov Tech Nutri Food Sci. 1(1).NTNF.000502. 2017.

7. Biomarker Tests and Ageing Science. Ageing Sci Ment Health Stud. 2017; 1(1): 1–2.

8. Autoimmune disease and mitochondrial dysfunction in chronic diseases. Res Chron Dis (2017) 1(1).

9. The Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer’s Disease. Proteomes, 2016. 4(2) 1-19.